Topic 1: Cell Communication [2-5] Flashcards

Define the cell as the basic unit of physiology Describe how signals can cross membranes Explain the different types of cell: cell communication Explain the different ways by which signals can be released from cells Give examples of different types of receptors Describe different speed of responses from multiple receptors Give examples to illustrate how the same signal can have multiple outcomes depending on the receptor Demonstrate how cell signalling pathways have potential as drug targets

1
Q

What is the cell-to-cell junction called that join adjacent cells and is used for small soluble signals?

A

Gap junctions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do a) Hydrophobic (1 way) and b) Hydrophilic (4 ways) molecules cross membranes?

A

a) Free diffusion
b) - Pumps / transporter
- ion channel
- vesicle fusion / fission (exo/endocytosis)
- indirectly, receptors & signalling pathways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name some examples of signalling molecules

A
  • proteins
  • peptides
  • amino acids
  • nucleotides
  • steroids (free diffusion)
  • fatty acids
  • ions
  • gasses (free diffusion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Ionic signals and signals released via exocytosis can be released either constitutively or evoked. What do these terms mean

A

Constitutive - passive flow down the concentration gradient

Evoked - channels can be gated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Secreted molecules mediate 4 forms of signalling, what are they and what are they used for (hint = paracrine etc)

A

Paracrine signalling: Only affect cells in the immediate environment. The signal is terminated by:

  • Uptake into neighbouring cells
  • Destruction by extracellular enzymes
  • Sequestration by ECM

Autocrine signalling: Similar to paracrine but is confined to a specific cell type

Synaptic signalling: a specialised subtype of paracrine signalling

Endocrine signalling: secretion of hormones into the blood. Specificity maintained by only target cells having adequate receptors

(Signals that use gap junctions or gases do not need receptors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Specificity of signalling can be achieved by either Synaptic signalling or Endocrine signalling. Compare these two methods

A

Synaptic:
- Arises from the physical location of the signalling site and the receptor
- Therefore, diversity of neurotransmitters is small
- Short distance (the synapse itself)
- Fast
- Receptors are low affinity

Endocrine:
- Arises from the combination of different signalling molecules being recognised by many different receptors
- Therefore a wide range of signals + receptors are needed
- Long distance
- Slow
- Receptors are high affinity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Match the type of receptor to the function:

a) Generate new signals inside the cell (second messengers)
b) Allow flow of ions across membranes
c) Modify existing molecules to generate new signals
d) Changes expression of genes

  • Steroid
  • Ionotropic
  • Kinase
  • Metabotropic
A

a) Metabotropic
b) Ionotropic
c) Kinase
d) Steroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Name the two types of ionotropic receptor and the types of ions they effect

A

Excitatory - Influx of positive ions
Inhibitory - Influx of negative ions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the general function of metabotropic (G-protein-linked) receptors?

A

They act indirectly to regulate the activity of a plasma-membrane-bound target protein such as an enzyme or an ion channel.

The intermediate between the receptor and the target is a trimeric G-protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens when a ligand binds a metabotropic receptor i.e. it is activated (in relation to the alpha, beta and gamma subunits)

A

Ligand binding causes the ALPHA subunit to release GDP for GTP causing:
1) Activation of the ALPHA-subunit
2) Release of the BETA/GAMMA-subunits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Ligand binding to a metabotropic receptor causes a series of changes such as a) ALPHA-subunit activation and b) BETA/GAMMA-subunit release. How do these above changes affect the cell

A

a) Activation of the ALPHA-subunit alters enzyme activities and changes concentration of intracellular signals (2nd messengers)

b) Release of BETA/GAMMA-subunits sometimes causes modifications to ion channel activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is signalling from metabotropic receptors terminated

A

Hydrolysis of GTP to GDP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Kinase receptors are either enzymes themselves or associated with enzymes. Most have a transmembrane domain with a ligand binding site outside the cell and enzyme activity inside the cell.

What happens when a ligand binds a kinase receptor (in relation to phosphorylation)?

A

1) Kinase receptors phosphorylate themselves
2) Their signal is amplified via a series of phosphorylation reactions
3) Signals are terminated via the action of phosphatases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How do steroid receptors work

A

1) Steroids freely diffuse across the plasma membrane
2) Once inside they bind to intracellular receptors, activating them
3) All steroid receptors bind to specific DNA sequences
4) Ligand binding activates gene transcription causing a 2 step response
5a) Direct transcription of a small number of genes
5b) These genes activate other genes and produce a secondary response

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How fast are the 4 receptors response times (relatively) and what are they limited by

A

Ionotropic - Very fast. Limited by:
- receptor pore size
- diffusion gradient

Metabotropic - Relatively fast. Limited by:
- number of enzymatic reactions in the cell

Kinase - Relatively fast. Limited by:
- number of enzymatic reactions in the cell

Steroid - Relatively slow. Limited by:
- speed of gene transcription

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Receptors can be targets for drugs in either an agonistic or antagonistic fashion. What do these terms mean in this context and what are the 2 types of antagonism (hint = steric / function)

A

Agonist: Mimic the natural ligand for the receptor and thus activate it even in the absence of the natural signal

Antagonist: Block the action of the natural ligand inhibiting the action of the receptor

There are 2 types of antagonist:
- Direct antagonism: directly compete with ligand for binding
- Allosteric antagonism: Inhibit receptor function by binding at a different site

17
Q

Development of the kidney involves a variety of signalling molecules relaying information between the ureteric bud and the metanephrogenic mesenchyme. What are some signals and their function in ureteic branching

A

TGFb + BMP4: Elongation
BMP7: Go Straight
BMP2: Keep Out
GDNF: Branch

18
Q

Define ‘weak emergence’

A

Weak emergence is essentially the overall effect of a combination of different interactions in a biological system. An example is kidney development that utilises a variety of different signals and receptors to stimulate growth.

19
Q

Match the stage of kidney development to what’s happening:

a) Specification of the intermediate mesoderm into the nephrogenic mesoderm
b) Nephron mesoderm divides into nephron progenitor cells
c) Simultaneous with b), the UB grows and branches
d) UB induces nephron progenitors to differentiate into specific cell types
e) Forms the distinct structures of the kidney such as glomerulus and renal tube
f) Development of blood vessels

  • Nephron maturation
  • Vascularisation
  • Kidney specification
  • Ureteric bud formation
  • Nephron formation
  • Reciprocal induction
A

a) Kidney specification
b) Nephron formation
c) UB formation
d) Reciprocal induction
e) Nephron maturation
f) Vascularisation

20
Q

What is the definition of a drug?

A

a chemical that produces a biological effect when given to a living organism

21
Q

What additional criteria do the FDA outline when considering drugs

A
  • its structure must be known
  • a drug is not a nutrient or essential dietary requirement

This separates drugs from medicines

22
Q

The advent of DNA technology has led to the introduction of many drugs that are broadly named biopharmaceuticals. What 3 biological mechanisms do these include?

A
  • Enzymes and blood components
  • Hormones
  • Humanised monoclonal antibodies (Mab)
23
Q

What 2 major principles govern the therapeutic use of drugs against disease

A
  • Selectivity: selective action on the target tissue
  • Specificity: this interaction between drug and target should be unique/specific (usually unmet = side effects)
24
Q

What is the definition of a receptor in the context of drug administration

A

any target molecule with which a drug has to combine in order to elicit its desired effect

25
Q

What are the 4 recognised drug targets

A
  • Receptors
  • Ion channels
  • Enzymes
  • Transporters (carrier molecules)
26
Q

The AFFINITY of a drug to bind to its target can be quantified in terms of an equilibrium constant: Ka from the Hill Langmuir equation:

[AR]/[RT] = [A]/Ka // [A]/Ka +1

What does each symbol stand for

A

[AR] = drug receptor complex concentration
[RT] = total number of receptors concentration
[A] = concentration of drug
Ka= Equilibrium constant (mol/l) for drug A binding to R

27
Q

In the context of drugs, what is the equilibrium constant

A

The concentration of a drug which occupies 50% of the available receptors. The smaller its value, the higher the affinity of the drug.

28
Q

What is the definition of efficacy

A

the ability of an agonist, once bound to the target, to elicit an effect

29
Q

What is the difference between FULL agonists and PARTIAL agonists

A

full: elicit the maximum response from a tissue
partial: cannot elicit the maximum response no matter how much drug is applied

30
Q

What is the definition of an antagonist in relation to efficacy and affinity

A

Drugs that bind with high specificity to a receptor but do not produce a response. They possess affinity but no efficacy

31
Q

Give the definition of:
a) Competitive reversible antagonism
b) Competitive irreversible antagonism
c) Allosteric modulators

A

a) Bind reversibly to the same site as the agonist
b) Same but bind irreversibly
c) Drugs that bind to a site distinct from the agonist binding site of a receptor but modulate the agonist response (can +ively or -ively affet response)